Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like Pharma Giant AstraZeneca PLC Scores Another FDA Breakthrough July 31, 2017 What Biogen Wants in Return for Financial Assistance of Its $750,000 a Year Drug June 11, 2017 Despite Expansion Overall, Roche Diabetes Care Lays Off 157 March 14, 2017